You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Guanzhou, China
    SunYat-senU
May 5, 2023

A Multicountry, Multicentre, Non-interventional, Retrospective

Recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Kuwait, Kuwait
      Kuwait Cancer Control Center
    Sep 13, 2023

    NSCLC Trial in China (BBP-398, osimertinib)

    Recruiting
    • NSCLC
    • Beijing, Beijing, China
    • +4 more
    Sep 4, 2023

    Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

    Completed
    • Metastatic Non-Small Cell Lung Cancer
    • East Hanover, New Jersey
      18 Novartis Investigative Sites in the US
    Dec 29, 2022

    Lung Cancer Trial (Savolitinib, Durvalumab)

    Recruiting
    • Lung Cancer
    • Beijing, China
    • +2 more
    Jan 11, 2023

    NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

    Suspended
    • NSCLC
    • Winter Haven, Florida
      Bond Clinic, P.A.
    Jan 27, 2023

    Locally Advanced or Metastatic NSCLC Trial in Ohio City (PBF-1129)

    Active, not recruiting
    • Locally Advanced or Metastatic NSCLC
    • Ohio City, Ohio
      Division of medical Oncology A450B Starling Loving Hall
    Jan 24, 2023

    KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)

    Recruiting
    • KRAS P.G12C
    • Non Small Cell Lung Cancer
    • Sotorasib 120Mg Tab
    • Lyon, France
    • +3 more
    Dec 16, 2022

    Non-Small-Cell Lung Cancer Trial in Shanghai (Furmonertinib (160mg))

    Recruiting
    • Non-Small-Cell Lung Cancer
    • Furmonertinib (160mg)
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 2, 2022

    Lazertinib as the 2nd-Line Treatment in EGFR Mutation+ NSCLC

    Completed
    • Non-small Cell Lung Cancer
    • (no location specified)
    May 8, 2023

    Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples

    Recruiting
    • Non-squamous Lung Cancer
    • Metastatic Lung Cancer
    • Blood
    • +3 more
    • Tours, France
      University hospital
    Nov 7, 2022

    Metastatic Non Small Cell Lung Cancer, KRAS G12C Trial in Worldwide (Sotorasib, Lenvatinib)

    Not yet recruiting
    • Metastatic Non Small Cell Lung Cancer
    • KRAS G12C
    • Innsbruck, Austria
    • +14 more
    Sep 28, 2023

    NSCLC (NSCLC) Trial in New York (Pembrolizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • New York, New York
      Mount Sinai Hospital
    Jan 23, 2023

    NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Melanoma
    • (no location specified)
    Jan 24, 2023

    NSCLC (NSCLC) Trial (Ociperlimab, Placebo, Tislelizumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Mar 17, 2023

    Non Small Cell Lung Cancer Trial in Shanghai (HS-10241)

    Recruiting
    • Non Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Jun 19, 2022

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Jul 17, 2022

    NSCLC Trial (KB-GDT-01)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • KB-GDT-01
    • (no location specified)
    Sep 29, 2023

    Advanced or Metastatic NSCLC Trial in Guangzhou (HS-10375)

    Recruiting
    • Advanced or Metastatic NSCLC
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 27, 2022

    NSCLC Trial in Changsha, Shanghai, Hangzhou (H002 capsule)

    Recruiting
    • Non-small Cell Lung Cancer
    • H002 capsule
    • Changsha, Hunan, China
    • +2 more
    Sep 20, 2022

    NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

    Terminated
    • Non-Small Cell Lung Cancer
    • Heidelberg, Victoria, Australia
      Austin Health
    Jan 13, 2023

    Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

    Recruiting
    • Metastatic Non-Small Cell Lung Carcinoma
    • Pembrolizumab Injection
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 6, 2022

    Locally Advanced or Metastatic NSCLC Patients, Progressed From

    Active, not recruiting
    • Locally Advanced or Metastatic NSCLC
      • Beijing, China
      • +16 more
      Dec 16, 2022